Search results
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Morningstar· 2 days agoGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential ...
Nanobiotix reports progress and financial results for 2023 By Investing.com
Investing.com· 2 days agoThe company highlighted the expansion of its radioenhancer NBTXR3's global potential through a...
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Morningstar· 1 week agoEssential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules Reminyl® is an established CNS brand for the symptomatic treatment of mild to moderately severe ...